Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking Glass
- PMID: 32631742
- DOI: 10.1016/j.eururo.2020.06.059
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking Glass
Comment on
-
Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence.Eur Urol. 2020 Sep;78(3):304-306. doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7. Eur Urol. 2020. PMID: 32389443 Free PMC article.
-
Platinum Opinion Counterview: The Evidence Base for the Benefit of Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis is Sound.Eur Urol. 2020 Sep;78(3):307-309. doi: 10.1016/j.eururo.2020.05.038. Epub 2020 Jun 12. Eur Urol. 2020. PMID: 32540172 No abstract available.
-
Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6: Prebiopsy MRI: Through the Looking Glass.Eur Urol. 2020 Sep;78(3):310-313. doi: 10.1016/j.eururo.2020.06.005. Epub 2020 Jul 11. Eur Urol. 2020. PMID: 32660749 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
